1.
|
Phase: Phase IV Type: Diagnostic Status: Closed Age: 25 and over Sponsor: Other Protocol IDs: PEM-06-01, NIH Grant: 5 R44 CA103102-05, NCT00484614
|
|
2.
|
Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-96079, NCI-G97-1334, NCT00002930
|
|
3.
|
Phase: Phase III, Phase II Type: Diagnostic Status: Closed Age: Not specified Sponsor: NCI Protocol IDs: MSKCC-97007, NCI-G97-1232, NCT00002981
|
|
4.
|
Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 15 and over Sponsor: Other Protocol IDs: SP-11-0035/DX-FDG-001/21221, NCT00123760
|
|
5.
|
Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UPCC-12199, UPCC-414500, NCT00194337
|
|
6.
|
Phase: Phase III, Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: FLT101, NCT00847509
|
|
7.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Completed Age: 18 to 75 Sponsor: Other Protocol IDs: POLEM (ZonMW DO 945-11017), (ZonMW DO 945-11017), NCT00119899
|
|
8.
|
Phase: Phase III Type: Diagnostic Status: Closed Age: no age specified Sponsor: Other Protocol IDs: CTRP024, NSC 92-2314-B-182A-084, NCT00146458
|
|
9.
|
Phase: Phase III Type: Diagnostic Status: Completed Age: 18 to 80 Sponsor: Other Protocol IDs: CTA-Control-088421, NCT00147472
|
|
10.
|
Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CTA-Control-092493, NCT00201942
|
|
11.
|
Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: P020907, NCT00236275
|
|
12.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NLG PET Study, NCT00286832
|
|
13.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSI3926g, ML20773, NCT00453362
|
|
14.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: CDR0000553410, EORTC-24051, EUDRACT-2006-002667-33, GSK-EORTC-24051, NCT00498953
|
|
15.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N057K, N057K, NCT00553150
|
|
16.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MGH-07-344, 07-344, PHS 398/2590, 8030, NCT00662506
|
|
17.
|
Phase: Phase II Type: Diagnostic Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: NCI-97-C-0068
|
|
18.
|
Phase: Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067385, MSKCC-99004, NCI-G99-1619, NCT00004152
|
|
19.
|
Phase: Phase II Type: Treatment Status: Closed Age: 4 to 35 Sponsor: NCI Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979
|
|
20.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-03032, NCI-5917, NCT00062374, 5917
|
|
21.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: ACRIN-6668, RTOG-0235, NCT00083083
|
|
22.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SG015-0005, NCT00086333
|
|
23.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6228, P30CA015704, UWCC-6228, UWCC-UW-6228, UW-04033, LILY-UW-04033, CDR0000441239, NCT00227539
|
|
24.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: LU-11-0044/DX-FDG-007/21389, NCT00123747
|
|
25.
|
Phase: Phase II Type: Diagnostic Status: Completed Age: 15 and over Sponsor: Other Protocol IDs: SP-14-0038/DX-FDG-003/21386, NCT00123773
|